Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Post by RazeKreationson Jun 21, 2021 4:31pm
156 Views
Post# 33421942

Microbix is the only listed domestic manufacturer of VTM

Microbix is the only listed domestic manufacturer of VTMThis is an article from INVEST ONTARIO

Microbix Biosystems is a publicly traded biotechnology company that specializes in infectious disease diagnostics, developing and manufacturing a wide range of biological materials to enhance human wellbeing. They have produced an extensive range of proprietary diagnostic antigens and Quality Assessment Products (
QAPs) that are used to test for human pathogens, including those that cause respiratory (COVID-19, flu, etc.), maternal, pediatric, childhood, sexually transmitted and insect-borne diseases, as well as being used to ensure that such testing is performed accurately. The company also produces a proprietary viral transport medium (VTM, brand DxTM™) to stabilize patient samples for lab-based molecular diagnostic testing. Notably, Microbix is the only listed domestic manufacturer of VTM. With over three decades of experience, Microbix continues to develop high-quality products for the global diagnostics industry. Their infectious disease antigens are sold to international OEM companies, and QAPs are sold to clinical laboratory accreditation organizations, diagnostics OEMs and clinical laboratories in Canada and overseas. DxTM is currently sold to support clinical testing within Canada.
<< Previous
Bullboard Posts
Next >>